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ABSTRACT 
Objective: The main objective of this study is to improve existing therapies and find new drugs based on dendrimers. Nanoparticle drug-delivery systems are able to increase 
the  selectivity  and  stability  of  therapeutic  agents.  However  reticuloendothelial  system  (RES)  uptake,  drug  leakage,  immunogenicity,  hemolytic  toxicity,  cytotoxicity, 
hydrophobicity restrict the use of these nanostructures. These shortcomings are overcome by surface engineering by the dendrimer such as Polyester dendrimer, Citric acid 
dendrimer, Arginine dendrimer, Glycodendrimers, PEGylated dendrimers, etc.Conclusion: From this present review study, we concluded that dendrimers can work as a 
useful tool for optimizing drug delivery of such problematic drugs. Also the problem of biocompatibility and toxicity can be overcome by careful surface engineering 
Keywords: Dendrimers, Synthesis, Dosage Forms, Characterization, Functions & its importance. 
INTRODUCTION 
A dendrimer is generally described as a macromolecule, which is 
characterized by its highly branched 3D structure that provides a 
high  degree  of  surface  functionality  and  versatility.  Dendrimers 
have often been referred to as the “Polymers of the 21
st century”. 
The word “dendrimer” originated from two words, the Greek word 
Dendron, meaning tree, and meros, meaning part. At the same 
time,  Newkome’s  group
.  independently  reported  synthesis  of 
similar macromolecules. They called them arborols from the Latin 
word ‘arbor’ also meaning a tree. The term cascade molecule is 
also used, but ‘dendrimer’ is the best established one. Due to their 
multivalent  and  monodisperse  character,  dendrimers  have 
stimulated  wide  interest  in  the  field  of  chemistry  and  biology, 
especially  in  applications  like  drug  delivery,  gene  therapy  and 
chemotherapy.  Dendrimers  are  branching  molecules  with  the 
branching beginning at the core. [1] Depending on the core, the 
dendrimer can start with 3 to 8 (or more) branches, with 3 and 4 
being  the  most  common  number.  Starting  from  the  core,  the 
dendrimer consists of long chains of atoms with a branch point 
about every half dozen atoms. At each branch point, the current 
chain  of  atoms  becomes  two  chains  of  atoms.  The  molecular 
structure has the form of a tree with a great number of branches. 
 
Fig.1: Dendrimers: A novel drug delivery system 
STRUCTURE 
Dendrimers are built from a starting atom, such as nitrogen, to 
which carbon and other elements are added by a repeating series 
of  chemical  reactions  that  produce  a  spherical  branching 
structure. As the process repeats, successive layers are added, 
and  the  sphere  can  be  expanded  to  the  size  required  by  the 
investigator. Dendrimers possess three distinguished architectural 
components, namely  
(i) An initiator core.  
(ii)Interior layers composed of repeating units, radically attached 
to the interior core.  
(iii)  Exterior  (terminal  functionality)  attached  to  the  outermost 
interior generations.  
 
Fig.2: The Dendritic Structure [2] 
TYPES OF DENDRIMERS [3] 
PAMAM Dendrimer 
Poly (amidoamine) dendrimers (PAMAM) are synthesized by the 
divergent  method  starting  from  ammonia  or  ethylenediamine 
initiator  core  reagents.  Starburst  dendrimers  is  applied  as  a 
trademark name for a sub-class of PAMAM dendrimers based on 
a tris-aminoethylene-imine core. 
PAMAMOS Dendrimers 
Poly(amidoamine-organosilicon)  dendrimers  (PAMAMOS)  are 
inverted  unimolecular  micelles  that  consist  of  hydrophilic, 
nucleophilic polyamidoamine (PAMAM) interiors and hydrophobic 
organosilicon (OS) exteriors. These dendrimers are exceptionally 
useful precursors for the preparation of honeycomb-like networks 
with nanoscopic PAMAM and OS domain. 
PPI Dendrimer 
PPI-dendrimers stand for “Poly (Propylene Imine)” PPI dendrimers 
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applications  in  material  science  as  well  as  in  biology.  As  an 
alternative name to PPI, POPAM is sometimes used to describe 
this  class  of  dendrimers.  POPAM  stands  for  Poly  (Propylene 
Amine). 
Tecto Dendrimer 
These  are  composed  of  a  core  dendrimer,  surrounded  by 
dendrimers  of  several  steps  (each  type  design)  to  perform  a 
function necessary for a smart therapeutic    nanodevice 
Multilingual Dendrimers 
In  these  dendrimers,  the  surface  contains  multiple  copies  of  a 
particular functional group.  
Chiral Dendrimers 
The chirality in these dendrimers are based upon the construction 
of  a constitutionally  different  but  chemically similar  branches to 
chiral core.  
Hybrid Dendrimers Linear Polymers 
These are hybrids (block or graft polymers) of dendritic and linear 
polymers.  
Amphiphilic Dendrimers 
They are built with two segregated sites of chain end, one half is 
electron donating and the other half is electron withdrawing.  
Micellar Dendrimers 
These are unimolecular micelles of water soluble hyper branched 
polyphenylenes.  
SYNTHESIS 
The synthesis used for dendrimer preparation permit almost entire 
control over the critical molecular design parameters such as size, 
shape, surface/interior chemistry, flexibility, and topology. Three 
types of dendrimers are formed [4]. 
‘Divergent’ Dendrimer Growth 
This  name comes  from  the  way  in  which  the  dendrimer  grows 
outwards from the core, diverging into space. Divergently grown 
dendrimers are virtually impossible to isolate pure from their side 
products.  The  first  synthesized  dendrimers  were 
polyamidoamines (PAMAMs). 
‘Convergent’  Dendrimer  Growth-  The  'convergent'  approach 
was  developed  as  a  response  to  the  weaknesses  of  divergent 
syntheses. Convergent growth begins at what will end up being 
the  surface  of  the  dendrimer,  and  works  inwards  by  gradually 
linking  surface  units  together  with  more.  The  advantages  of 
convergent  growth  over  divergent  growth  stem  that  only  two 
simultaneous  reactions  are  required  for  any  generation-adding 
step. 
a.  Relatively  easy  to  purify  the  desired  product  and  the 
occurrence of defects in the final structure is minimised.  
b.  Possible  to  introduce  subtle  engineering  into  the  dendritic 
structure  by  precise  placement  of  functional  groups  at  the 
periphery of the macromolecules.  
c.  Approach  does  not  allow  the  formation  of  high  generation 
dendrimer because stearic problems occur in the reactions of 
the dendrons and the core molecule. 
‘Double  Exponential’  And  ‘Mixed’  Growth-  The  most  recent 
fundamental breakthrough in the practice of dendrimers synthesis 
has  come  with  the  concept  and  implications  of  'double 
exponential'  growth.  A  schematic  representation  of  double 
exponential  and  mixed  growth.  This  approach  allows  the 
preparation  of  monomers  for  both  convergent  and  divergent 
growth  from  a  single  starting  material.  These  two  products  are 
reacted together to give an orthogonally protected trimer, which 
may be used to repeat the growth process again.        
Fig. 3: synthesis process of dendrimers [5] 
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PROPERTIES OF DENDRIMERS [7, 8] 
Table 1: Properties of dendrimers over linear polymers. 
Sr. No.   Property   Dendrimers   Linear Polymers  
1   Structure   Compact, Globular   Not compact  
2   Synthesis   Careful & stepwise growth   Single step polycondensation  
3   Structural control  Very high   Low  
4   Architecture   Regular   Irregular  
5   Shape   Spherical   Random coil  
6   Crystallanity   Non-crystalline, amorphous materials  
-lower glass temperatures  
Semi crystalline/crystalline materials  
-Higher glass temperatures  
   
7   Aqueous solubility   High   Low  
8   Nonpolar solubility   High   Low  
9   Viscosity   Non linear relationship with molecular weight   Linear relation with molecular weight  
10   Reactivity   High   Low  
11   Compressibility   Low   High  
12   Polydispersity   Monodisperse   Polydisperse  
METHOD OF CHARACTERIZATION FOR DENDRIMERS 
  Spectroscopy  and  spectrometry  methods  like  Nuclear 
Magnetic Resonance (NMR), Infra-red (IR) and Raman, Ultra-
violet-visible  (UV-VIS),  Fluorescence,  Chirality,  Optical 
rotation, Circular dichroism (CD), X-ray diffraction, and Mass 
spectrometry  
  Scattering  techniques  like  Small  angle  X-ray  scattering 
(SAXS),  Small  angle  neutron  scattering  (SANS),  and  Laser 
light scattering (LLS) 
  Electrical  techniques  like  Electron  paramagnetic  resonance 
(EPR), Electrochemistry, and Electrophoresis  
  Size exclusion chromatography (SEC)  
  Microscopy like Transmission electron microscopy, Scanning 
electron microscopy and atomic force microscopy 
 Miscellaneous  like  X-ray  Photoelectron  Spectroscopy  (XPS), 
measurements of dipole moments, titrimetry etc.[8,9,10] 
 
DOSAGE FORMS OF DENDRIMERS 
Cosmetics and personal care applications  
Because  of  their  excellent  carrier  properties,  dendrimers  have 
utility in cosmetics and personal care products such as hair-styling 
gels, shampoos, sunscreens, and anti-acne products. Cosmetic 
compositions  comprising  hydroxyl-functionalized  dendritic 
macromolecules  are  described  in  a  patent  filed  by  Unilever's 
Home & Personal Care division. Another patent filed by L'Oreal 
described  terminal  hydroxyl  functional  group  polyester  dendritic 
macromolecules in combination with film-forming polymers for use 
in cosmetic and dermatological products intended for application 
to  the  skin,  keratinous  fibers,  nails,  or  mucous  membranes.
[11] 
Such  a  combination  of  a  film-forming  polymer  with  a  dendritic 
polymer allowed the inventors to develop a low-viscosity product 
that was easily applied to the intended topical skin site and that 
formed a dry film capable of being peeled-off after the application 
period 
[43]. 
Dendrimers as ophthalmic vehicles 
The  majorities  of  topically  applied  ocular  drug-delivery  systems 
are formulated either as solutions, ointments, or suspensions and 
suffer from various disadvantages such as quick elimination from 
the precorneal region, poor bioavailability, or failure to deliver the 
drug in a sustained fashion.
[12,13] Several research advances have 
been made in ocular drug delivery systems by using specialized 
delivery systems such as polymers, liposomes, or dendrimers to 
overcome some of these disadvantages. Some recent research 
efforts  in  dendrimers  for  ocular  drug  delivery  include  PAMAM 
dendrimers that   were studied by    Vandamme and    Brobeck as  
 
 
 
 
ophthalmic  vehicles  for  controlled  delivery  of  pilocarpine  and 
tropicamide to the eye. 
Topical and transdermal delivery 
 Dendrimers have found recent applications in novel topical and 
transdermal  delivery  systems,  providing  benefits  such  as 
improved drug solubilization, controlled release, and drug-polymer 
conjugates (pro-drugs). The viscosity-generation-number property 
of  a  dendrimer  solution  allows  for  ease  of  handling  of  highly 
concentrated  dendrimer  formulations  for  these  applications. 
Dendrimers have been shown to be useful as transdermal and 
topical  drug  delivery  systems  for  nonsteroidal  anti-inflammatory 
drugs  (NSAIDs),  antiviral,  antimicrobial,  anticancer,  or 
antihypertensive drugs. PAMAM dendrimers have been studied as 
carrier transdermal  systems for the model NSAIDs: ketoprofen 
and diflunisal [14]. 
FUNCTION OF DENDRIMERS 
In August 2000, we began tests in vivo. The in vivo tests  are to 
confirm that the nano-devices will work as therapeutic agents.[15, 
16] 
  Diseased cell recognition  
  Diagnosis of disease state  
  Drug delivery  
  Reporting location  
ADVANTAGES  OF  DENDRIMERS  OVER  OTHER  NOVEL 
DRUGS 
  Biocompatibility. 
  Non-toxicity. 
  Non-irritability. 
  Thermodynamically stable in the body. 
  Ability  to  reach  places  in  the  body  inaccessible  to  more 
massive red blood cells. 
  High solubility in water. 
  High oxygen solubility. 
  Efficient rate of oxygen transfer into an aqueous phase. 
 
The greatest advantage of dendrimers technology is possibly the 
potential  for  very  cost-effective  manufacturing,  Because 
dendrimers are not derived from human or animal sources and 
manufacturing  techniques  are  relatively  simple  and  thoroughly 
established, if a dendrimers was identified that was an effective  
hemoglobin  substitute  the  cost  of  manufacturing  would  be 
dramatically less than that of current HBOCs and even transfused 
blood. [17, 18, 19] 
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APPLICATIONS 
Pharmaceutical Application 
Dendrimers Drug Delivery: Targeted And Controlled Release 
Drug Delivery  
Dendrimers  have  attracted  attention  as  possible  drug  carriers 
because of their unique properties namely their well deﬁned three-
dimensional structure, the availability of many functional surface 
groups,  their  low  polydispersity  and  their  ability  to mimic.  Drug 
molecules can be loaded both in the interior of the dendrimers as 
well as attached to the surface groups. Dendrimers can function 
as drug carriers either by encapsulating drugs within the dendritic 
structure, or by inter-acting with drugs at their terminal functional 
groups via electrostatic or covalent bonds (prodrug) [20].
  
Noncovalent Encapsulation of Drugs / Host –Guest Relation  
Encapsulation of drugs use the satiric bulk of the exterior of the 
dendrimer or Interactions between the dendrimer and drug to trap 
the drug inside the dendrimer. Maciejewski introduced the concept 
of  encapsulating  guest  molecules  into  special,  egg-shell-like 
structures. Such a system can be used to encapsulate drugs and 
provide  controlled  delivery.  For  example,  in  early  studies,  DNA 
was  complexed  with  PAMAM  dendrimers  for  gene  delivery 
applications [21]. 
Covalent Dendrimer–Drug Conjugates  
An  alternative  approach  to  the  development  of  dendrimers  as 
anticancer  drug  carriers  is  to  exploit  their  well-defined 
multivalency for the covalent attachment of drug molecules to the 
dendrimers periphery. In dendrimer–drug conjugates, the drug is 
attached  through  a  covalent  bond  either  directly  or  via  a 
linker/spacer to the surface groups of a dendrimer. Dendrimers 
have  been  conjugated  to  various  biologically  active  molecules 
such as drugs, antibodies, sugar moieties and lipids. Conjugates 
of  PAMAM  dendrimers  with  cisplatin,  a  potent  anticancer  drug 
with  non-specific  toxicity  and  poor  water  solubility  [22,  23].The 
conjugates show increased solubility, decreased systemic toxicity 
and selective accumulation in solid tumors. 
Dendrimer as Solubility Enhancers  
There  are  many  substances,  which  have  a  strong  therapeutic 
activity  but  due  to  their  lack  of  solubility  in  pharmaceutically 
acceptable solvents have not been used for therapeutic purposes. 
Water soluble dendrimers are capable of binding and solubilizing 
small acidic hydrophobic molecules with antifungal or antibacterial 
properties.  Dendrimers  having  a  hydrophobic  core  and  a 
hydrophilic  surface  layer,  have  been  termed  unimolecular 
micelles.  A  hydrophilic–hydrophobic  core-shell  dendrimer  with 
PAMAM interior and long alkane chain exterior was shown to bind 
5-flurouracil, a water-soluble anti-tumor drug [24]. 
Cellular Delivery Using Dendrimer Carriers  
Dendrimer–ibuprofen  complexes  entered  the  cells  rapidly 
compared  with  pure  drug  (1  hr  versus>3  hr),  suggesting  that 
dendrimers can efficiently carry the complexed drug inside cells 
[25].  PAMAM  dendrimers  were  surface-engineered  with  lauryl 
chains to reduce toxicity and enhance cellular uptake.  
Dendrimers As Nano-Drugs 
Poly(lysine) dendrimers modified with sulfonated naphthyl groups 
have been found to be useful as antiviral drugs against the herpes 
simplex virus can potentially prevent/reduce transmission of HIV 
and  other  sexually  transmitted  diseases  (STDs).  Chitosan–
dendrimer hybrids have been found to be useful as antibacterial 
agents, carriers in drug delivery systems, and in other biomedical 
applications [26, 27].  
Dendrimers In Photodynamic Therapy 
The  photosensitizer  5-aminolevulinic  acid  has  been  attached to 
the surface of dendrimers and studied as an agent for PDT of 
tumorigenic  keratinocytes  .Photos  ensitive  dyes  have  been 
incorporated into dendrimers and utilized in PDT devices[28]. This 
cancer treatment involves the administration of a light- activated 
photosensitizing  drug  that  selectively  concentrates  in  diseased 
tissue. 
Dendrimers In Gene Transfection  
Dendrimers  can  act  as  vectors,  in  gene  therapy.  PAMAM 
dendrimers  have  been  tested  as  genetic  material  carriers. 
Numerous  reports  have  been  published  describing  the  use  of 
amino-terminated PAMAM or PPI dendrimers as  non-viral gene 
transfer agents, enhancing the transfection of DNA by endocytosis 
and,  ultimately,  into  the  cell  nucleus  [29,  30].  A  transfection 
reagent called SuperFectTM consisting of activated dendrimers is 
commercially available. 
Non-Pharmaceutical Application 
Diagnostics 
Paramagnetic  metal  chelates  such  as  Gd(III)-  N,N’,N’’,N”’-
tetracarboxymethyl-1,4,7,10-tetraazacy-clododecane  (Gd(III)-
DOTA),  Gd(III)-diethylene  tri-  amine  pentaacetic  acid  (Gd(III)-
DTPA), and their derivatives used as contrast agents for magnetic 
resonance imaging(MRI). DNA-dendrimers, which are constructed 
for routine, use in high-throughput functional genomics analysis, 
and  as  biosensors  for  the  rapid  diagnosis  have  genetic,  and 
pathogenesis diseases [31]. 
Dendritic Catalysts / Enzymes  
The combination of high surface area and high solubility makes 
dendrimers  useful  as  nanoscale  catalysts.  Dendrimers  have  a 
multifunctional surface and all catalytic sites are always exposed 
towards the reaction mixture [32, 33, 34, 35]. 
  Metallodendritic catalysts. 
  Catalysis with phosphine-based dendrimers.  
  Catalysis  with  (metallo)  dendrimers  containing  chiral 
ligands. 
  Non-metal containing dendrimers. 
Industrial Processes  
Dendrimers can encapsulate insoluble materials, such as metals, 
and  transport  them  into  a  solvent  within  their  interior  [36,  37]. 
Cooper and co-workers synthesized fluorinated dendrimers, which 
are  soluble  in  supercritical  CO2  and  can  be  used  to  extract 
strongly hydrophilic compounds from water into liquid CO2. 
Sensors 
Scientists  have  also  studied  dendrimers  for  use  in  sensor 
technologies. Studied systems include proton or pH sensors using 
poly  (propyleneimine),  cadmium  -   sulfide  /polypropylenimine 
tetrahexaamine  dendrimers  composites  to  detect  fluorescence 
signal quenching [38, 39, 40]. 
CONCLUSION 
The  dendrimers  holds  a  promising  future  in  various 
pharmaceutical  applications  and  diagnostic  field  in  the  coming 
years as they possess unique properties, such as high degree of 
branching,  multivalency,  globular  architecture  and  well-defined 
molecular weight, thereby offering new scaffolds for drug delivery. 
An  increasingly  large  number  of  drugs  being  developed  today 
facing problems of poor solubility, bioavailability and permeability. 
Dendrimers can work as a useful tool for optimizing drug delivery 
of such problematic drugs. Also the problem of biocompatibility 
and  toxicity  can  be  overcome  by  careful  surface  engineering. 
Recent successes in simplifying and optimizing the synthesis of 
dendrimers provide a large variety of structures with reduced cost 
of  their  production.  Also  as  research  progresses,  newer 
applications  of  dendrimers  will  emerge  and  the  future  should 
witness  an  increasing  numbers  of  commercialized  dendrimers 
based drug delivery systems.  
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